What is Deepsight Technology?
Founded in 2019 and headquartered in San Francisco, Deepsight Technology operates at the intersection of advanced computer vision and medical diagnostics. The company specializes in the development of sophisticated sensing technologies designed to enhance the efficacy of medical imaging systems. By integrating artificial intelligence with high-fidelity sensing hardware, Deepsight Technology addresses critical gaps in diagnostic workflows, providing clinicians with clearer, more actionable data. Their market position is defined by a focus on transformative healthcare solutions that aim to improve patient outcomes through technological innovation. As a specialized player in the medical device sector, the company bridges the gap between raw data acquisition and clinical decision support, establishing itself as a vital component in the modern healthcare technology stack.
How much funding has Deepsight Technology raised?
Deepsight Technology has raised a total of $25M across 1 funding round:
Series A
$25M
Series A (2021): $25M with participation from Wing Venture Capital, Time BioVentures, Deerfield, and Alter Venture Partners
Key Investors in Deepsight Technology
Wing Venture Capital
Wing Venture Capital is an early-stage investor and long-term company builder that focuses on equipping founders with resources and unwavering partnerships to develop innovative products.
Time BioVentures
Time BioVentures is a full-spectrum healthcare and life sciences venture capital firm that finances innovative entrepreneurs developing transformative healthcare technologies.
Deerfield
Deerfield Management is an investment firm focused on advancing healthcare through investment, intelligence, and philanthropy, supporting companies across the healthcare ecosystem.
What's next for Deepsight Technology?
Looking ahead, the strategic deployment of the $25M will likely focus on scaling production capabilities and expanding the company's footprint within the global healthcare market. With the support of seasoned venture partners, Deepsight Technology is poised to refine its diagnostic algorithms and pursue regulatory milestones necessary for broader clinical adoption. The company's roadmap suggests a shift toward deeper integration with existing hospital infrastructure, ensuring that their sensing technology becomes a standard tool for diagnostic precision. By prioritizing long-term value creation and technological scalability, Deepsight Technology is set to influence the future of medical imaging, potentially setting new benchmarks for diagnostic speed and accuracy in the enterprise healthcare sector.
See full Deepsight Technology company page
